EUVIMEDEUVIMED entdecken
Open Access

Calnexin promotes glioblastoma progression by inducing protective mitophagy through the MEK/ERK/BNIP3 pathway

Xuchen Liu, Jiangli Zhao, Qingyuan Sun, Zhiwei Xue, Ziyi Tang, Wenyu Liu, Junzhi Liu, Baojian Miao, Nan Su, Yanya He, Yuehua Zhu, Bin Huang und 4 weitere

Theranostics · 27.01.2025 · 15 (6) · 2624-2648

DOI: 10.7150/thno.105591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 27.01.2025. Verfasst von Xuchen Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, 250012…. Hauptthemen laut MEDLINE: Glioblastoma, Membrane Proteins, Mitophagy, Calnexin. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Glioblastoma multiforme (GBM), one of the most malignant tumors of the central nervous system, has a poor prognosis, mainly because of its high recurrence caused by the rapid development of drug resistance to postoperative chemotherapy. Although macroautophagy/autophagy is believed to be a fundamental factor in tumor survival during chemotherapy, there is still a lack of autophagy biomarkers for predicting patient prognosis and chemotherapeutic efficacy in clinical practice.

Methods

We combined transcriptomic and single-cell sequencing data to identify differentially expressed autophagy-related genes in gliomas. Overexpression of calnexin (CANX), a key gene related to protein folding, and its secretion in the endoplasmic reticulum (ER) was identified, suggesting poor prognosis in GBM patients. The autophagy flow related to CANX was detected by transmission electron microscopy (TEM), Western blotting, and immunofluorescence. Flow cytometry, cell proliferation, activity assays, and the GBM intracranial xenograft mouse model were employed to validate CANX's role in GBM progression.

Results

CANX knockdown inhibited proliferation and autophagosome formation in GBM cells. On the other hand, CANX overexpression increased mitogen-activated protein kinase (MAPK) activity, leading to the accumulation of BNIP3 (CL2/adenovirus E1B 19 kDa interacting protein 3, a critical factor regulating mitophagy) and protective mitophagy. Notably, when combined with temozolomide (TMZ), CANX knockdown extended the lifespan of GBM-bearing mice. Additionally, our studies revealed that the classic calcium inhibitor nimodipine (ND) decreased CANX expression and thus enhanced the sensitivity to TMZ.

Conclusions

Our findings indicate that CANX functions as an oncogene in GBM. We also characterize the CANX/MEK/ERK/BNIP3 mitophagy pathway, provide new insights into the molecular mechanism of GBM drug resistance, and identify a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMembrane ProteinsMitophagyCalnexinBrain NeoplasmsProto-Oncogene ProteinsMAP Kinase Signaling SystemHumansAnimalsMiceCell Line, TumorTemozolomideCell ProliferationAutophagyXenograft Model Antitumor AssaysDisease ProgressionMice, NudeGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

calnexinglioblastomamitophagynimodipinetemozolomide

Substanzen

Membrane ProteinsCalnexinBNIP3 protein, humanProto-Oncogene ProteinsTemozolomide

Autor:innen und Institutionen

  • Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, 250012 Jinan, China.
  • Jinan Microecological Biomedicine Shandong Laboratory and Shandong Key Laboratory of Brain Function Remodeling, 250117 Jinan, China.
  • School of Medicine, Cheeloo College of Medicine, Shandong University, 250012 Jinan, China.

Zitieren

APA

Liu, X., Zhao, J., Sun, Q., Xue, Z., Tang, Z., Liu, W., Liu, J., Miao, B., Su, N., He, Y., Zhu, Y., Huang, B., Yang, N., Li, C., Wang, J., & Wang, X. (2025). Calnexin promotes glioblastoma progression by inducing protective mitophagy through the MEK/ERK/BNIP3 pathway. Theranostics, 15(6), 2624-2648. https://doi.org/10.7150/thno.105591

Vancouver

Liu X, Zhao J, Sun Q, Xue Z, Tang Z, Liu W, et al. Calnexin promotes glioblastoma progression by inducing protective mitophagy through the MEK/ERK/BNIP3 pathway. Theranostics. 2025;15(6):2624-2648. doi:10.7150/thno.105591

BibTeX
@article{Liu2025,
  author = {Liu, Xuchen and Zhao, Jiangli and Sun, Qingyuan and Xue, Zhiwei and Tang, Ziyi and Liu, Wenyu and Liu, Junzhi and Miao, Baojian and Su, Nan and He, Yanya and Zhu, Yuehua and Huang, Bin and Yang, Ning and Li, Chao and Wang, Jiwei and Wang, Xinyu},
  title = {Calnexin promotes glioblastoma progression by inducing protective mitophagy through the MEK/ERK/BNIP3 pathway},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {6},
  pages = {2624--2648},
  doi = {10.7150/thno.105591}
}
Kostenlos starten →